We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Pipettes Offer Quality Assurance for Endotoxin-Sensitive Applications

By LabMedica International staff writers
Posted on 11 May 2010
A range of serological pipettes is now certified nonpyrogenic to 0.01 ELISA Units (EU)/mL, significantly lower than the market standard of 0.25 EU/mL. More...
The range has also been validated nonhemolytic.

When medical device and pharmaceutical manufacturers perform tests to ensure that their products are free from endotoxins, it is extremely important for them to have confidence in the equipment and materials that they use.

Similarly, when pipetting blood and blood products, it is important that the polymer used does not have a detrimental effect on the sample. Validated nonhemolytic, the serological pipettes protect samples and provide valuable assurance that they will not interfere with the results of hemolysis tests.

Certified nonpyrogenic to a very low level, Sterilin (Bargoed, UK) serological pipettes greatly reduce the risk of endotoxin interference in routine laboratory analyses (such as limulus amebocyte lysate--LAL testing) and, therefore, help to ensure the integrity of results.

Sterilin serological pipettes are manufactured from crystal grade polystyrene to ensure excellent clarity. With crisp black print, ascending and descending graduations, and negative graduations for extra capacity, volumes are extremely easy to read, and accurate to ± 1%.

The comprehensive range includes standard pipette sizes (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, and 50 mL) in addition to "Shortie” pipettes (5 mL and 10 mL), which are ideal for use in laminar flow cabinets. The gamma-irradiated pipettes are individually wrapped in paper peel or plastic film to maintain quality during storage.

Related Links:

Sterilin




New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
NATtrol Chlamydia trachomatis Positive Control
New
Silver Member
Autoimmune Hepatitis Test
LKM-1-Ab ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.